WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma

Phase 2

Completed

Conditions: Soft Tissue Sarcoma, Adult
Soft Tissue Sarcoma, Child

Interventions: Drug: Pembrolizumab
Drug: Doxorubicin

First Posted Date: 2017-02-16

Last Posted Date: 2023-11-18

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 30

Registration Number: NCT03056001

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Sedation Methods During Cataract Surgery

Phase 4

Completed

Conditions: Phacoemulsification
Cataract

Interventions: Drug: Midazolam + Normal saline

First Posted Date: 2017-02-15

Last Posted Date: 2018-09-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 105

Registration Number: NCT03054103

Evaluating Treatment Resistant Dermatitis TaroIIR

Phase 4

Completed

Conditions: Psoriasis
Atopic Dermatitis

Interventions: Behavioral: Phone calls
Drug: Desoximetasone 0.25% spray

First Posted Date: 2017-02-10

Last Posted Date: 2020-05-20

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 24

Registration Number: NCT03050294

Locations: 🇺🇸
Wake Forest University Health Sciences Department of Dermatology, Winston-Salem, North Carolina, United States

MED in UVB Devices in the Presence and Absence of UV Filter

Not Applicable

Withdrawn

Conditions: Healthy Participants and/or Patients

Interventions: Device: Psoriashield in the presence of a non-UV absorbing block.
Device: Psoriashield in the presence of a UV absorbing block.
Device: Psoriashield
Device: Xtrac laser in the presence of a non-UV absorbing block.
Device: Xtrac in the presence of a UV absorbing block.
Device: Xtrac laser

First Posted Date: 2017-02-10

Last Posted Date: 2019-08-29

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT03049319

Locations: 🇺🇸
Elias Oussedik, Winston-Salem, North Carolina, United States

Internet Surveys and Their Impact on Adherence for Rosacea

Phase 4

Completed

Conditions: Rosacea

Interventions: Drug: brimonidine topical gel 0.33% & SOC
Drug: brimonidine topical gel 0.33% & survey

First Posted Date: 2017-02-09

Last Posted Date: 2018-10-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 20

Registration Number: NCT03048058

Locations: 🇺🇸
Dept of Dermatology, WFUHS, Winston-Salem, North Carolina, United States

Evaluating Dysphagia in Neonates With CHD

Terminated

Conditions: Dysphagia of Newborn

First Posted Date: 2017-02-07

Last Posted Date: 2024-10-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT03045757

Locations: 🇺🇸
Advocate Children's Hospital, Oak Lawn, Illinois, United States

Pre-Shave Gel and Brush in Pseudofolliculitis Barbae

Not Applicable

Completed

Conditions: Pseudofolliculitis Barbae

Interventions: Other: shave gel
Other: Brush

First Posted Date: 2017-02-06

Last Posted Date: 2018-12-19

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 29

Registration Number: NCT03043534

Locations: 🇺🇸
Wake Forest University Health Sciences Dept of Dermatology, Winston-Salem, North Carolina, United States

Cryosurgery and Cream Combination for Actinic Keratosis

Phase 3

Completed

Conditions: Actinic Keratosis

Interventions: Drug: Placebo Cetaphil cream
Drug: Carac Cream

First Posted Date: 2017-01-31

Last Posted Date: 2018-08-29

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT03037541

Locations: 🇺🇸
Wake Forest University Health Sciences Department of Dermatology, Winston-Salem, North Carolina, United States

COcoa Supplement and Multivitamin Outcomes Study for the Mind

Completed

Conditions: Dementia
Aging
Cognitive Impairment

First Posted Date: 2017-01-27

Last Posted Date: 2023-08-22

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 2262

Registration Number: NCT03035201

Locations: 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Not Applicable

Completed

Conditions: Stage II Laryngeal Squamous Cell Carcinoma
Stage IV Lip and Oral Cavity Squamous Cell Carcinoma
Paranasal Sinus Squamous Cell Carcinoma
Stage I Laryngeal Squamous Cell Carcinoma
Stage I Lip and Oral Cavity Squamous Cell Carcinoma
Stage III Oropharyngeal Squamous Cell Carcinoma
Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma
Stage IVB Hypopharyngeal Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Laryngeal Squamous Cell Carcinoma

Interventions: Other: Watch video
Other: Communication Intervention
Other: Module completion of the Prepare to Care kit
Other: Quality-of-Life Assessment
Other: Survey Administration
Other: Salivary cortisol collection

First Posted Date: 2017-01-26

Last Posted Date: 2023-01-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 35

Registration Number: NCT03032250

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Home Terms & Conditions Privacy Policy